开云app官网登录入口网页版-官方正版

[GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113294, encodeId=039b111329458, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-08-19 ms7000000034057106 来自广东省

审稿速度:3.0 | 投稿命中率:50.0
偏重的研究方向：肾脏病
经验分享：还行

24 0

[GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113294, encodeId=039b111329458, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2023-07-27 没证的蒲肯野来自浙江省

投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭

80 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113294, encodeId=039b111329458, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2022-10-14 xc494192838

几个小时就under review不知道是不是只是内审而非外审

126 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113294, encodeId=039b111329458, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-06-28 MsyR 来自山东省

刚投完一个original article，稿件编号700多

44 0

[GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113294, encodeId=039b111329458, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-03-21 ms4000000293208382 来自山东省

这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113294, encodeId=039b111329458, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2024-03-21 ms4000000293208382 来自山东省

这个期刊还要求共享数据吗？

54 0

[GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113294, encodeId=039b111329458, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-27 Mia

推荐同行评议时需要注意哪些情况？

148 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2221370, encodeId=c60422213e0c6, content=审稿速度:3.0 | 投稿命中率:50.0 偏重的研究方向：肾脏病 经验分享：还行, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=edda6166630, createdName=ms7000000034057106, createdTime=Mon Aug 19 18:38:32 CST 2024, time=2024-08-19, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2150068, encodeId=74fd2150068fe, content=投稿后就是显示under review，投了2个月了，一直是under review状态，编辑那里显示not assigned，2个月了还没分配编辑😭, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=80, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyhT9kz3nRX3CNUxnAZReddZHd5jjSx2xXuWyap1l87JLKYsDHtMVfZbgJjnuHyic6nDKPDh3PNIPnv/0, createdBy=86ac2048709, createdName=没证的蒲肯野, createdTime=Thu Jul 27 09:18:17 CST 2023, time=2023-07-27, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2093810, encodeId=d4a3209381080, content=几个小时就under review不知道是不是只是内审而非外审, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=91591617845, createdName=xc494192838, createdTime=Fri Oct 14 19:31:01 CST 2022, time=2022-10-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212049, encodeId=66d92212049e4, content=刚投完一个original article，稿件编号700多, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=dee72041211, createdName=MsyR, createdTime=Fri Jun 28 09:10:30 CST 2024, time=2024-06-28, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194555, encodeId=a5e62194555da, content=这个杂志咋样啊，是SCI吗，是不是开办没多久的期刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 21:13:13 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2194573, encodeId=841121945e3e2, content=这个期刊还要求共享数据吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c4a9175564, createdName=ms4000000293208382, createdTime=Thu Mar 21 22:08:55 CST 2024, time=2024-03-21, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=1113293, encodeId=9cf91113293bf, content=推荐同行评议时需要注意哪些情况？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=148, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Mon Dec 27 14:52:55 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1113294, encodeId=039b111329458, content=什么是correspondingauthor/通讯作者？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=146, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:55 CST 2021, time=2021-12-28, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

什么是correspondingauthor/通讯作者？

146 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务